Skip to main content

Table 1 Distribution of hrHPV genotypes

From: Our experience diagnosing 225 patients with cervical glandular lesions: current technologies, lessons learned, and areas for improvement

HPV types

AIS

ADC

MASL

Total (%)

16

7

23

44

74(29.48%)

18

10

27

54

91(36.25%)

31

0

0

1

1(0.40%)

33

0

4

2

6(2.39%)

45

0

1

11

12(4.78%)

51

0

0

3

3(1.20%)

52

2

1

6

9(3.59%)

58

1

0

0

1(0.40%)

59

0

1

1

2(0.80%)

62

0

0

1

1(0.40%)

66

0

0

1

1(0.40%)

68

0

0

1

1(0.40%)

hr-HPV

0

1

2

3(1.20%)

Not detected

0

7

10

17(6.77%)

Unknown

2

12

15

29(11.55%)

  1. Abbreviations: AIS, adenocarcinoma in situ; ADC, cervical adenocarcinoma;
  2. MASL, mixed glandular and squamous lesions; hr-HPV, high-risk HPV (infection rate)